Clinical Trial Update: AIR2 Extension Study to Demonstrate Longer-term (> 1 Year) Durability of Effectiveness

View source ↗

Summary

The AIR2 extension study for bronchial thermoplasty in asthma has completed and reported results assessing durability of effectiveness beyond one year.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Alair System (bronchial thermoplasty)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Asthma | Status: COMPLETED | Results posted: 2016-09-26